Struthers Richard Scott 4
4 · Crinetics Pharmaceuticals, Inc. · Filed Dec 18, 2025
Insider Transaction Report
Form 4
Struthers Richard Scott
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2025-12-18$9.28/sh+16,342$151,654→ 336,359 total - Exercise/Conversion
Common Stock
2025-12-18$15.29/sh+28,400$434,236→ 364,759 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-18−16,342→ 0 totalExercise: $9.28Exp: 2028-05-24→ Common Stock (16,342 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-18−28,400→ 259,058 totalExercise: $15.29Exp: 2031-02-26→ Common Stock (28,400 underlying)
Holdings
- 661,205(indirect: By Trust)
Common Stock
- 106,000(indirect: By Trust)
Common Stock
- 110,000(indirect: By Trust)
Common Stock
- 100,000(indirect: By Trust)
Common Stock
- 1,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
- [F2]1/48th of the shares subject to the option vested on April 16, 2018, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.